Definium Therapeutics (DFTX) total liabilities

Total liabilities · fiscal 2025
$107.77M

Definium Therapeutics (DFTX) had total liabilities of $107.77M at the end of fiscal 2025 (December 31, 2025). That is 77.5% higher than the $60.70M of fiscal 2024. Figures as of 19 Nov 2026, 03:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$107.77M
Change on fiscal 2024
+77.5%
Growth, 5 years
+80.3% a year
Highest on record
$107.77Mfiscal 2025
Lowest on record
$5.65Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Definium Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 80.3% a year. Across the 6 fiscal years on record (2020–2025), the highest was $107.77M in fiscal 2025 and the lowest $5.65M in fiscal 2020.

History · 6 fiscal years

Total liabilities by fiscal year

Definium Therapeutics total liabilities, year by year

Definium Therapeutics (DFTX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$107.77M 77.5% up
2024$60.70M 30.8% up
2023$46.41M 143.3% up
2022$19.08M 54.6% up
2021$12.34M 118.3% up
2020$5.65M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Definium Therapeutics and comparable companies
CompanyTotal liabilitiesFiscal year
Heartflow HTFL$58.81M2025
CRISPR Therapeutics CRSP$343.43M2025
Travere Therapeutics TVTX$490.36M2025
Option Care Health OPCH$2.13B2025
Legend Biotech LEGN$731.60M2025
Definium Therapeutics DFTX$107.77M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DFTX

Definium Therapeutics, figure by figure

Definium Therapeutics (DFTX) overview: price, valuation and scorecardAll health care companies by market value

Definium Therapeutics total liabilities: questions and answers

How large are Definium Therapeutics's total liabilities?

Definium Therapeutics (DFTX) had total liabilities of $107.77M at the end of fiscal 2025 (December 31, 2025). That is 77.5% higher than the $60.70M of fiscal 2024.

What is the growth rate of Definium Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 80.3% a year.

What are the highest and lowest total liabilities figures on record for Definium Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $107.77M in fiscal 2025 and the lowest $5.65M in fiscal 2020.

How is Definium Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Definium Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Definium Therapeutics (DFTX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/DFTX/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.